Bluejay Diagnostics (BJDX) Depreciation and Depletion (2022 - 2026)

Bluejay Diagnostics has disclosed Depreciation and Depletion across 5 years of filings, most recently posting $27763.0 for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $27763.0, up 50.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $83544.0 (up 12.43% YoY), and the FY2025 annual result was $74182.0, down 1.9% from the prior year.
• Depreciation and Depletion came in at $27763.0 for Q1 2026 at Bluejay Diagnostics, up from $27415.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $253175.0 in Q2 2023 to a low of $10624.0 in Q3 2025.
• The 5-year median for Depreciation and Depletion is $27415.0 (2025), against an average of $57815.8.
• Across the five-year window, Depreciation and Depletion surged 501.02% in 2023 and tumbled 93.02% in 2024, its largest moves.
• Bluejay Diagnostics' Depreciation and Depletion stood at $30682.0 in 2022, then slipped by 27.18% to $22342.0 in 2023, then retreated by 11.49% to $19775.0 in 2024, then soared by 38.63% to $27415.0 in 2025, then gained by 1.27% to $27763.0 in 2026.
• The last three Depreciation and Depletion figures came in at $27763.0 (Q1 2026), $27415.0 (Q4 2025), and $10624.0 (Q3 2025), per Business Quant data.